martes, 1 de septiembre de 2026

Pharmalittle: We’re reading about Novartis and Bristol pausing cell therapy trials, a $480K cancer drug, and more President Trump has announced the next round of pricing deals with drugmakers

https://www.statnews.com/pharmalot/2026/09/01/novartis-bristol-trials-paused-pancreatic-cancer-drug-price-pharmalittle-newsletter/ By Andrew JosephSept. 1, 2026 Europe Correspondent

No hay comentarios: